Administration Moves to Ban Synthetic Kratom, Boosting Sales of Botanical Supplements

The White House announced a ban on a potent synthetic form of kratom. The ban targets a chemically engineered version of the plant derivative. Officials said the synthetic product posed health and safety concerns. The decision removes competition for botanical kratom supplements. Manufacturers of natural kratom products had lobbied for the ban. Industry groups praised the move as a victory for consumer choice. Sales of the botanical supplements are expected to rise following the ban. Critics argue the policy may limit options for some users. The administration plans to monitor the market for compliance. The outcome highlights the influence of lobbying on drug policy.